Search Within

Irene Y Cheung

  1. "Hematologic Malignancies Research"
Formats
  1. Journal Article (3)
  2. Meeting Abstract (3)
Groups
  1. Alan and Sandra Gerry Metastasis and Tumor Ecosystems Center (6)
  2. Bone Marrow Transplant (6)
  3. Center for Hematologic Malignancies (6)
  4. Center for Molecular Imaging and Biotechnology (CMIB) (6)
  5. Department of Medicine (6)
  6. GSK Faculty (6)

More Groups

People
  1. Katharine Hsu (6)
  2. Nai-Kong Cheung (6)
  3. Bo Dupont (4)
  4. Jeffrey Venstrom (4)
  5. Junting Zheng (4)
  6. Karen Danis (3)

More People

Years
  1. 2018 (1)
  2. 2012 (1)
  3. 2011 (1)
  4. 2010 (1)
  5. 2009 (1)
  6. 2008 (1)
Publications
  1. Blood (1)
  2. Cancer Research (1)
  3. Clinical Cancer Research (1)
  4. Journal of Clinical Oncology (1)
  5. OncoImmunology (1)
  6. Pediatric Blood and Cancer (1)
Publishers
  1. American Association for Cancer Research (2)
  2. American Society of Clinical Oncology (1)
  3. American Society of Hematology (1)
  4. Landes Bioscience (1)
  5. Wiley Periodicals, Inc (1)

Results (6)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Adoptive immunotherapy with haploidentical natural killer cells and Anti-GD2 monoclonal antibody m3F8 for resistant neuroblastoma: Results of a phase I study
    Journal Article

    Modak, S.; Le Luduec, J. B.; Cheung, I. Y.; Goldman, D. A.; Ostrovnaya, I.; Doubrovina, E.; Basu, E.; Kushner, B. H.; Kramer, K.; Roberts, S. S.; more...
    OncoImmunology (2018)

    Fulltext@MSK | Save
  • Activation of peripheral-blood granulocytes is strongly correlated with patient outcome after immunotherapy with anti-GD2 monoclonal antibody and granulocyte-macrophage colony-stimulating factor
    Journal Article

    Cheung, I. Y.; Hsu, K.; Cheung, N. K. V.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • KIR/HLA genotypes predictive of missing KIR ligands are associated with improved outcome in patients with high-risk neuroblastoma treated with anti-GD2 monoclonal antibody therapy
    Meeting Abstract

    Gallagher, M.; Tarek, N.; Zheng, J. T.; Venstrom, J. M.; Cheung, I. Y.; Modak, S.; Dupont, B.; Cheung, N. K. V.; Hsu, K. C.
    Pediatric Blood and Cancer (2011)

    Fulltext@MSK | Save
  • NK cell killer Ig-like receptor (KIR) genotype as a novel biomarker for neuroblastoma patients receiving anti-GD2 monoclonal antibody 3F8
    Meeting Abstract

    Venstrom, J. M.; Zheng, J.; Kushner, B. H.; Modak, S.; Danis, K. E.; Cheung, I. Y.; Dupont, B.; Cheung, N. K.; Hsu, K. C.
    Cancer Research (2010)

    Fulltext@MSK | Save
  • KIR and HLA genotypes are associated with disease progression and survival following autologous hematopoietic stem cell transplantation for high-risk neuroblastoma
    Journal Article

    Venstrom, J. M.; Zheng, J.; Noor, N.; Danis, K. E.; Yeh, A. W.; Cheung, I. Y.; Dupont, B.; O'Reilly, R. J.; Cheung, N. K. V.; Hsu, K. C.
    Clinical Cancer Research (2009)

    Fulltext@MSK | Save
  • Lack of HLA class I ligands for autologous inhibitory KIR is associated with improved survival following autologous stem cell transplant for children with neuroblastoma
    Meeting Abstract

    Venstrom, J. M.; Zheng, J.; Hasan, R. S.; Danis, K. E.; Cheung, I. Y.; Dupont, B.; Cheung, N. K.; Hsu, K. C.
    Blood (2008)

    Fulltext@MSK | Save